Company Overview and News

0
EIGR / Eiger BioPharmaceuticals, Inc. FORM 8-K (Current Report)

2018-08-13 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
EIGR

0
30
Your Daily Pharma Scoop: Foundation Promising, Paratek Moves Up, Ovid Down

2018-08-08 seekingalpha
Discussion: Foundation Medicine’s (FMI) announced a positive outcome of its bTMB assay. In a recent publication in Nature Medicine, a retrospective analysis of more than one thousand samples from NSCLC patients who participated in Roche (OTCQX:RHHBY) Genetech’s trials showed that use of Foundation Medicine’s (FMI) blood tumor mutational burden (‘bTMB) assay would have helped predict responses to TECENTRIQ (atezolizumab).
INO GILD PRTK TEVA OVID TEVVF ELTP SSKN PTIE MELA TEVJF EIGR PTGX FMI PFE

22
Your Daily Pharma Scoop: IPO Review - Crinetics And Provention Float IPO, Bionano Files

2018-07-24 seekingalpha
After a little lull around the July Fourth holidays, the biotech IPO scene is abuzz again. Many of the IPOs floated are of very early stage companies, but for some others the market seems to be excited by their early stage results. In the following review we present the prospects of a few such companies.
XERS TEVA EIGR NVS ZEAL LLY CRNX CHMA PFE PRVB

0
Crinetics IPO: Shares At 2.7x Its Cash Per Share With Competitors Trading At 6-7x

2018-07-21 seekingalpha
Crinetics is focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
IONS EIGR CAMRF CRNX CHMA

3
Is a Surprise Coming for Brown & Brown (BRO) This Earnings Season?

2018-07-19 zacks
Investors are always looking for stocks that are poised to beat at earnings season and Brown & Brown, Inc. (BRO - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
NBRV EIGR BRO NCS

3
Should You Buy Sierra (BSRR) Ahead of Earnings?

2018-07-19 zacks
Investors are always looking for stocks that are poised to beat at earnings season and Sierra Bancorp (BSRR - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. That is because Sierra is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for BSRR in this report.
BSRR NBRV EIGR NCS

3
Is a Surprise Coming for 1st Constitution Bancorp (FCCY) This Earnings Season?

2018-07-19 zacks
Investors are always looking for stocks that are poised to beat at earnings season and 1st Constitution Bancorp (FCCY - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. That is because 1st Constitution Bancorp is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to earnings beat.
NBRV EIGR FCCY NCS

6
Berkshire Hathaway (BRK-B) Soars: Stock Adds 5.3% in Session

2018-07-19 zacks
Berkshire Hathaway Inc. (BRK.B - Free Report) was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $184.91 to $192.00 in the past one-month time frame.
BRK.A HALL NBRV EIGR NCS

3
CSX Corporation (CSX) Catches Eye: Stock Jumps 7.1%

2018-07-19 zacks
CSX Corporation (CSX - Free Report) was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $63.59 to $66.50 in the past one-month time frame. The move came after the company reported solid second-quarter 2018 results.
GWR NBRV EIGR CSX NCS

3
United Continental (UAL) in Focus: Stock Moves 8.8% Higher

2018-07-19 zacks
United Continental Holdings, Inc. (UAL - Free Report) was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $68.88 to $74.42 in the past one-month time frame.
NBRV EIGR UAL ATSG NCS

3
PPG Industries (PPG) Q2 Earnings, Sales Beat Estimates

2018-07-19 zacks
PPG Industries, Inc. (PPG - Free Report) , based in Pennsylvania, has a diversified business and a leading position in several paints and coatings end markets. Earnings PPG Industries’ adjusted earnings were $1.90 per share for the second quarter, up around 6% year over year. It beat the Zacks Consensus Estimate of $1.89. Revenues PPG Industries posted revenues of $4,131 million, up roughly 9% year over year.
PPG NBRV EIGR NCS

3
MGIC Investment (MTG) Soars: Stock Adds 9.1% in Session

2018-07-19 zacks
MGIC Investment Corporation (MTG - Free Report) was a big mover last session, as the company saw its shares rise more than 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $10.71 to $11.37 in the past one month time frame.
NBRV EIGR LGGNY MTG NCS

3
Why Cleveland-Cliffs (CLF) Might Surprise This Earnings Season

2018-07-19 zacks
Investors are always looking for stocks that are poised to beat at earnings season and Cleveland-Cliffs Inc. (CLF - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. That is because Cleveland-Cliffs is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to earnings beat.
NBRV EIGR NCS

3
Is a Surprise Coming for Halliburton (HAL) This Earnings Season?

2018-07-19 zacks
Investors are always looking for stocks that are poised to beat at earnings season and Halliburton Company (HAL - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
NBRV EIGR NCS

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

CUSIP: 28249U105